Evidence map›Paper›PMID 35877706›Full record

ArticleMarine drugs2022

Oral Supplementation with

Masaki Honda, Hakuto Kageyama, Yelin Zhang, Takashi Hibino, Motonobu Goto

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Absorption characteristics andRSC advances · 2025
    Article
  3. Review
  4. Protective Effect of Zeaxanthin fromAntioxidants (Basel, Switzerland) · 2025
    Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. ACS omega · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Masaki HondaFaculty of Science & Technology, Meijo University, 1-501 Shiogamaguchi, Tempaku-ku, Nagoya 468-8502, Japan.ORCID 0000-0001-9470-7442
Hakuto KageyamaFaculty of Science & Technology, Meijo University, 1-501 Shiogamaguchi, Tempaku-ku, Nagoya 468-8502, Japan.ORCID 0000-0002-7741-7408
Yelin ZhangFaculty of Science & Technology, Meijo University, 1-501 Shiogamaguchi, Tempaku-ku, Nagoya 468-8502, Japan.ORCID 0000-0002-0390-5484
Takashi HibinoFaculty of Science & Technology, Meijo University, 1-501 Shiogamaguchi, Tempaku-ku, Nagoya 468-8502, Japan.
Motonobu GotoInstitute of Innovation for Future Society, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan.ORCID 0000-0003-3219-5028
Meijo University · JPNagoya University · JP

Funding

Japan Science and Technology Agency JPMJTR20U7
6 · The paper itself

Abstract

The effect of oral supplementation with astaxanthin of different

Indexed as

Ultraviolet RaysXanthophyllsAnimalsDietary SupplementsGuinea PigsSkinastaxanthineXanthophyllsAstaxanthinelasticitygeometrical isomerguinea pigsmelanin synthesisskin damagetransepidermal water lossUV-light irradiation

Identifiers

PMID35877706
PMCPMC9315510
OpenAlexW4283577039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.